| Trial ID: | L4009 |
| Source ID: | NCT00697450
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Weight effect, 12 months prior to and 12 months after detemir treatment. | Secondary: Improvement in FPG levels, 12 months prior and 12 months after detemir treatment|Improvement in HbA1c levels, 12 months prior and 12 months after detemir treatment
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
206
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-07
|
| Completion Date: |
2009-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-23
|
| Locations: |
Novo Nordisk Investigational Site, Prague, 16000, Czech Republic
|
| URL: |
https://clinicaltrials.gov/show/NCT00697450
|
